Abbott’s iFS advanced femtosecond laser has received FDA clearance for use in corneal and cataract surgeries to create bow-shaped or curved arcuate incisions, the company announced. The fifth generation of IntraLase technology, iFS laser is currently used to create lasik flaps and other corneal incisions. The device allows surgeons to make precise, bladeless arcuate incisions during surgery and to customize each incision. The placement, length, depth and radius of curvature can influence the surgeon’s desired change to the cornea. These parameters are often difficult to control through traditional incisions made by hand using surgical knives. “This is a major advancement and expansion of our femtosecond laser technology,” said Jim Mazzo, senior vice president of Abbott Medical Optics. “This is an important step as we look to utilize femtosecond laser technology as a potential standard of care during the cataract procedure.” The femtosecond laser is now available in the US. Abbott develops and manufactures pharmaceuticals and medical products. For more information, visit: www.abbott.com